Adverse drug reactions (ADRs) are a major public health issue, especially in low-resource settings where underreporting is common; mHealth apps could improve ADR reporting efficiently.
A study in Ethiopia surveyed 422 healthcare professionals and found that 77.4% were willing to use mobile applications for ADR reporting, with their willingness influenced by factors like smartphone use, training, attitude, and perceived ease and usefulness of the apps.
The findings highlight the potential for mHealth apps to enhance pharmacovigilance practices among healthcare professionals in resource-constrained areas, indicating a need for more training and resources.